Clinical Trials Using Anti-c-Met Antibody-drug Conjugate HTI-1066
Clinical trials are research studies that involve people. The clinical trials on this list are studying Anti-c-Met Antibody-drug Conjugate HTI-1066. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors
HTI-1066 is a novel ADC being developed for the treatment of cancers in patients with overexpression of c-Met. This 2-part, Phase 1 study evaluates the safety the tolerability of HTI-1066 in subjects with advanced solid tumors.
Location: See Clinical Trials.gov